SONYA LOVINGOOD: Open Payments
NPI 1043612906 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$451 in 23 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $86 · 2025 $451
Food & beverage: $451
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $106 |
| Lundbeck LLC | 4 | $82 |
| Esperion Therapeutics, Inc. | 3 | $51 |
| Lilly USA, LLC | 2 | $45 |
| ABBVIE INC. | 2 | $30 |
| Astellas Pharma US Inc | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: Wegovy, VYEPTI, NEXLETOL, Rybelsus, REXULTI, VRAYLAR, ZEPBOUND, Veozah.
Industry payments across WA — which companies pay providers there.
